Covered recipient · General Payments record
JOHN MONGAN
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2019–2025
$2,477.02
- Reported across 112 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $356.08 | 14 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $95.67 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $40.00 | 1 |
| Incyte Corporation | $29.83 | 1 |
| ARRAY BIOPHARMA INC | $27.11 | 1 |
| Exelixis Inc. | $23.09 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $22.11 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $21.85 | 1 |
| Acerta Pharma LLC | $21.76 | 1 |
| GlaxoSmithKline, LLC. | $20.22 | 1 |
| SERVIER PHARMACEUTICALS LLC | $19.36 | 1 |
| PFIZER INC. | $19.14 | 1 |
| Tempus AI, Inc | $15.94 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.75 | 07/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203116252 | CMS |
| ABBVIE INC. | $34.65 | 08/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203116256 | CMS |
| ABBVIE INC. | $27.27 | 11/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203116260 | CMS |
| ARRAY BIOPHARMA INC | $27.11 | 05/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230548734 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.76 | 04/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206302479 | CMS |
| Exelixis Inc. | $23.09 | 05/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1218796015 | CMS |
| GlaxoSmithKline, LLC. | $20.22 | 07/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190469125 | CMS |
| Incyte Corporation | $29.83 | 04/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1226085227 | CMS |
| Novartis Pharmaceuticals Corporation | $22.11 | 01/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200732005 | CMS |
| PFIZER INC. | $19.14 | 02/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230630490 | CMS |
| PUMA BIOTECHNOLOGY, INC. | $21.85 | 03/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251744557 | CMS |
| SERVIER PHARMACEUTICALS LLC | $19.36 | 10/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229101193 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $40.00 | 05/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223938898 | CMS |
| Tempus AI, Inc | $15.94 | 09/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250349193 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.